Please login to the form below

Not currently logged in

Roche's Louis Renzetti joins PPD in senior lab role

Takes up role as VP of strategic laboratory operations at the CRO

The former global head of Roche's RNA therapeutics division Louis Renzetti has moved to contract research organisation (CRO) PPD to take up the role of VP of strategic laboratory operations.

Renzetti has more than 20 years' experience in drug discovery, spending more than half of them with Roche where he held a series of senior leadership positions.

As global head of the pharma company's RNA therapeutics division Renzetti led the company's efforts to advance a revolutionary therapeutic platform to treat severe diseases such as cancer.

PPD's executive vice president of global lab services and chief scientific officer Lee Babiss said: "Lou brings strong pharmaceutical expertise to help us build and strengthen our strategic lab partnerships with pharma, biotech, academia and government clients.

"His leadership will be instrumental as we continue implementing innovative new strategies to integrate our laboratory and phase I services with our phase II-IV services to provide clients with end-to-end, value-chain capabilities."

Renzetti completed postdoctoral training in pharmacology at ICI Pharmaceuticals, now part of AstraZeneca, and his subsequent drug discovery work has included stints as a pharmacologist, drug development specialist and therapeutic area leader.

18th July 2012


Featured jobs

Subscribe to our email news alerts


Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...